{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:30:34Z","timestamp":1790101834081,"version":"4.0.1"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Retinopathy of prematurity (ROP) is an evolutive and potentially blinding eye disease that affects preterm newborns. Unfortunately, until now no conservative therapy of active ROP with proven efficacy is available. Although ROP is a multifactorial disease, premature exposition to oxygen concentrations higher than those intrauterine, represents the initial pathogenetic trigger. The increase of oxygenation in a retina still incompletely vascularized promotes the downregulation of proangiogenic factors and finally the interruption of vascularization (ischemic phase). However, the increasing metabolic requirement of the ischemic retina induces, over the following weeks, a progressive hypoxia that specularly increases the levels of proangiogenic factors finally leading to proliferative retinopathy (proliferative phase). Considering non-modifiable the coupling between oxygen levels and vascularization, so far, neonatologists and ophthalmologists have \u201cplayed defense\u201d, meticulously searching the minimum necessary concentration of oxygen for individual newborns, refining their diagnostic ability, adopting a careful monitoring policy, ready to decisively intervene only in a very advanced stage of disease progression. However, recent advances have demonstrated the possibility to pharmacologically modulate the relationship between oxygen and vascularization, opening thus the perspective for new therapeutic or preventive opportunities. The perspective of a shift from a defensive towards an attack strategy is now at hand.<\/jats:p>","DOI":"10.3389\/fphar.2022.835771","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T07:22:51Z","timestamp":1642749771000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Decoupling Oxygen Tension From Retinal Vascularization as a New Perspective for Management of Retinopathy of Prematurity. New Opportunities From \u03b2-adrenoceptors"],"prefix":"10.3389","volume":"13","author":[{"given":"Luca","family":"Filippi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Cammalleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Ciantelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dal Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1001\/jama.2018.5725","article-title":"Association between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-Analysis Collaboration","volume":"319","author":"Askie","year":"2018","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1056\/NEJMoa023080","article-title":"Oxygen-saturation Targets and Outcomes in Extremely Preterm Infants","volume":"349","author":"Askie","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"L1073","DOI":"10.1152\/ajplung.00347.2006","article-title":"Hyperoxia Reduces Bone Marrow, Circulating, and Lung Endothelial Progenitor Cells in the Developing Lung: Implications for the Pathogenesis of Bronchopulmonary Dysplasia","volume":"292","author":"Balasubramaniam","year":"2007","journal-title":"Am. J. Physiol. Lung Cel. Mol. Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1515\/jpm-2015-0357","article-title":"Oral Propranolol in Early Stages of Retinopathy of Prematurity","volume":"44","author":"Bancalari","year":"2016","journal-title":"J. Perinat. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.ophtha.2020.12.028","article-title":"Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-vascular Endothelial Growth Factor","volume":"128","author":"Barry","year":"2021","journal-title":"Ophthalmology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-021-01385-x","article-title":"Infantile Hemangiomas \u03b23-adrenoceptor Overexpression Is Associated with Nonresponse to Propranolol","author":"Bassi","year":"2021","journal-title":"Pediatr. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1056\/NEJMoa1514212","article-title":"Outcomes of Two Trials of Oxygen-Saturation Targets in Preterm Infants","volume":"374","author":"Boost-II Australia","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"666334","DOI":"10.3389\/fphar.2021.666334","article-title":"\u03b2 3 Adrenergic Receptor Stimulation Promotes Reperfusion in Ischemic Limbs in a Murine Diabetic Model","volume":"12","author":"Bubb","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1113\/jphysiol.2003.045112","article-title":"Chronic Hypoxia Increases Blood Pressure and Noradrenaline Spillover in Healthy Humans","volume":"551","author":"Calbet","year":"2003","journal-title":"J. Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1111\/bph.14660","article-title":"\u03b23 -Adrenoceptor as a Potential Immuno-Suppressor Agent in Melanoma","volume":"176","author":"Calvani","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fncel.2017.00395","article-title":"The Beta Adrenergic Receptor Blocker Propranolol Counteracts Retinal Dysfunction in a Mouse Model of Oxygen Induced Retinopathy: Restoring the Balance between Apoptosis and Autophagy","volume":"11","author":"Cammalleri","year":"2017","journal-title":"Front. Cel Neurosci."},{"key":"B12","first-page":"649","article-title":"Potent and Selective Human Beta(3)-Adrenergic Receptor Antagonists","volume":"290","author":"Candelore","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.preteyeres.2014.06.001","article-title":"The \u03b2-adrenergic System as a Possible New Target for Pharmacologic Treatment of Neovascular Retinal Diseases","volume":"42","author":"Casini","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/labinvest.3700277","article-title":"Differential Expression of Pro- and Antiangiogenic Factors in Mouse Strain-dependent Hypoxia-Induced Retinal Neovascularization","volume":"85","author":"Chan","year":"2005","journal-title":"Lab. Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0219934","DOI":"10.1371\/journal.pone.0219934","article-title":"Risk Factor Analysis for the Development and Progression of Retinopathy of Prematurity","volume":"14","author":"Chang","year":"2019","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1167\/iovs.12-9691","article-title":"Propranolol Inhibition of \u03b2-adrenergic Receptor Does Not Suppress Pathologic Neovascularization in Oxygen-Induced Retinopathy","volume":"53","author":"Chen","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1161\/hh1901.098042","article-title":"Upregulation of Functional Beta(3)-Adrenergic Receptor in the Failing Canine Myocardium","volume":"89","author":"Cheng","year":"2001","journal-title":"Circ. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International Classification of Retinopathy of Prematurity, Third Edition","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1167\/iovs.16-20822","article-title":"Use of a Supplemental Oxygen Protocol to Suppress Progression of Retinopathy of Prematurity","volume":"58","author":"Colaizy","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/s0161-6420(01)01015-6","article-title":"A Comparison of Laser Photocoagulation with Cryotherapy for Threshold Retinopathy of Prematurity at 10 years: Part 2. Refractive Outcome","volume":"109","author":"Connolly","year":"2002","journal-title":"Ophthalmology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e20162904","DOI":"10.1542\/peds.2016-1576","article-title":"Cummings JJ, Polin RA, COMMITTEE ON FETUS AND NEWBORN. Oxygen Targeting in Extremely Low Birth Weight Infants","volume":"138","author":"Cummings","year":"2016","journal-title":"Pediatrics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1167\/iovs.14-15263","article-title":"Protective Effects of \u03b21\/2 Adrenergic Receptor Deletion in a Model of Oxygen-Induced Retinopathy","volume":"56","author":"Dal Monte","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exer.2013.03.013","article-title":"Eye Drop Propranolol Administration Promotes the Recovery of Oxygen-Induced Retinopathy in Mice","volume":"111","author":"Dal Monte","year":"","journal-title":"Exp. Eye Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00210-012-0828-x","article-title":"Beta3-adrenergic Receptors Modulate Vascular Endothelial Growth Factor Release in Response to Hypoxia through the Nitric Oxide Pathway in Mouse Retinal Explants","volume":"386","author":"Dal Monte","year":"","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1167\/iovs.11-9408","article-title":"Beta-adrenoreceptor Agonism Influences Retinal Responses to Hypoxia in a Model of Retinopathy of Prematurity","volume":"53","author":"Dal Monte","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1111\/apa.15945","article-title":"The Prenatal Phase of Retinopathy of Prematurity","volume":"110","author":"Dammann","year":"2021","journal-title":"Acta Paediatr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.clp.2013.02.006","article-title":"Setting up and Improving Retinopathy of Prematurity Programs: Interaction of Neonatology, Nursing, and Ophthalmology","volume":"40","author":"Darlow","year":"2013","journal-title":"Clin. Perinatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1161\/01.CIR.0000139331.85766.AF","article-title":"Endothelial Beta3-Adrenoceptors Mediate Vasorelaxation of Human Coronary Microarteries through Nitric Oxide and Endothelium-dependent Hyperpolarization","volume":"110","author":"Dessy","year":"2004","journal-title":"Circulation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/archdermatol.2010.1295","article-title":"Characteristics of Infantile Hemangiomas as Clues to Pathogenesis: Does Hypoxia Connect the Dots?","volume":"146","author":"Drolet","year":"2010","journal-title":"Arch. Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised Indications for the Treatment of Retinopathy of Prematurity: Results of the Early Treatment for Retinopathy of Prematurity Randomized Trial","volume":"121","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e20183810","DOI":"10.1542\/peds.2018-381037","article-title":"American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening Examination of Premature Infants for Retinopathy of Prematurity","volume":"143","author":"Fierson","year":"2019","journal-title":"Pediatrics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/pr.2016.230","article-title":"Propranolol 0.1% Eye Micro-drops in Newborns with Retinopathy of Prematurity: a Pilot Clinical Trial","volume":"81","author":"Filippi","year":"2017","journal-title":"Pediatr. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.jpeds.2013.07.049","article-title":"Oral Propranolol for Retinopathy of Prematurity: Risks, Safety Concerns, and Perspectives","volume":"163","author":"Filippi","year":"2013","journal-title":"J. Pediatr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fped.2019.00180","article-title":"Propranolol 0.2% Eye Micro-drops for Retinopathy of Prematurity: A Prospective Phase IIB Study","volume":"7","author":"Filippi","year":"2019","journal-title":"Front. Pediatr."},{"key":"B35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2431-10-83","article-title":"Study Protocol: Safety and Efficacy of Propranolol in Newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491","volume":"10","author":"Filippi","year":"2010","journal-title":"BMC Pediatr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1167\/iovs.12-10721","article-title":"Different Efficacy of Propranolol in Mice with Oxygen-Induced Retinopathy: Could Differential Effects of Propranolol Be Related to Differences in Mouse Strains?","volume":"53","author":"Filippi","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/med.21336","article-title":"Infantile Hemangiomas, Retinopathy of Prematurity and Cancer: a Common Pathogenetic Role of the \u03b2-adrenergic System","volume":"35","author":"Filippi","year":"2015","journal-title":"Med. Res. Rev."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/med.21874","article-title":"\u03b23\u2010Adrenoceptor, a Novel Player in the Round\u2010trip from Neonatal Diseases to Cancer: Suggestive Clues from Embryo","author":"Filippi","year":"2021","journal-title":"Med. Res. Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1056\/NEJMoa0911781","article-title":"Target Ranges of Oxygen Saturation in Extremely Preterm Infants","volume":"362","author":"Finer","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.preteyeres.2009.06.003","article-title":"The Neurovascular Retina in Retinopathy of Prematurity","volume":"28","author":"Fulton","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1733785","article-title":"Association of Surgical Necrotizing Enterocolitis and its Timing with Retinopathy of Prematurity","author":"Fundora","year":"2021","journal-title":"Am. J. Perinatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1161\/CIRCRESAHA.111.300152","article-title":"\u03b22-Adrenergic Receptor Stimulation Improves Endothelial Progenitor Cell-Mediated Ischemic Neoangiogenesis","volume":"112","author":"Galasso","year":"2013","journal-title":"Circ. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/archopht.130.1.117","article-title":"\u03b2-Blocking and Racial Variation in the Severity of Retinopathy of Prematurity","volume":"130","author":"Good","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/j.ophtha.2019.11.026","article-title":"Retinopathy of Prematurity Incidence in Children","volume":"127","author":"Good","year":"2020","journal-title":"Ophthalmology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e19282","DOI":"10.1371\/journal.pone.0019282","article-title":"Agonist-directed Desensitization of the \u03b22-adrenergic Receptor","volume":"6","author":"Goral","year":"2011","journal-title":"PLoS One"},{"key":"B46","first-page":"264","article-title":"Characterization of the Human Beta 3-adrenergic Receptor Gene","volume":"44","author":"Granneman","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2021.11.015","article-title":"Real-world Visual Outcomes of Laser and Anti-VEGF Treatments for Retinopathy of Prematurity","author":"Gundlach","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4161\/org.4.4.7415","article-title":"Role of VEGF in Organogenesis","volume":"4","author":"Haigh","year":"2008","journal-title":"Organogenesis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.preteyeres.2016.09.004","article-title":"The Neural Retina in Retinopathy of Prematurity","volume":"56","author":"Hansen","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1167\/iovs.13-13532","article-title":"The Vasoneuronal Effects of AT1 Receptor Blockade in a Rat Model of Retinopathy of Prematurity","volume":"55","author":"Hatzopoulos","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"104846","DOI":"10.1016\/j.earlhumdev.2019.104846","article-title":"Screening and Novel Therapies for Retinopathy of Prematurity - A Review","volume":"138","author":"Hellstr\u00f6m","year":"2019","journal-title":"Early Hum. Development"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of Prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/biomedicines9050468","article-title":"HIF-\u03b1 Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review","volume":"9","author":"Hirota","year":"2021","journal-title":"Biomedicines"},{"key":"B54","doi-asserted-by":"publisher","first-page":"E2516","DOI":"10.1073\/pnas.1523005113","article-title":"Comparative Systems Pharmacology of HIF Stabilization in the Prevention of Retinopathy of Prematurity","volume":"113","author":"Hoppe","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e17512","DOI":"10.1097\/MD.0000000000017512","article-title":"Cumulative Evidence for Association of Sepsis and Retinopathy of Prematurity","volume":"98","author":"Huang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"B56","first-page":"1217","article-title":"Vascularization of the Human Fetal Retina: Roles of Vasculogenesis and Angiogenesis","volume":"41","author":"Hughes","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1097\/01.iae.0000244293.94251.20","article-title":"Laser Treatment for Retinopathy of Prematurity: Evolution in Treatment Technique over 15 Years","volume":"26","author":"Hurley","year":"2006","journal-title":"Retina"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1124\/jpet.104.076901","article-title":"Evidence for Pleiotropic Signaling at the Mouse Beta3-Adrenoceptor Revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol Oxalate]","volume":"312","author":"Hutchinson","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1161\/01.RES.0000191541.06788.bb","article-title":"Ischemic Neoangiogenesis Enhanced by Beta2-Adrenergic Receptor Overexpression: a Novel Role for the Endothelial Adrenergic System","volume":"97","author":"Iaccarino","year":"2005","journal-title":"Circ. Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00210-012-0824-1","article-title":"Pharmacological Profile of \u03b23-adrenoceptor Agonists in Clinical Development for the Treatment of Overactive Bladder Syndrome","volume":"386","author":"Igawa","year":"2013","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1747-1028-8-1","article-title":"The Role of \u03b2-adrenergic Receptor Signaling in the Proliferation of Hemangioma-Derived Endothelial Cells","volume":"8","author":"Ji","year":"2013","journal-title":"Cell Div"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1021\/acs.jmedchem.7b01686","article-title":"Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases","volume":"61","author":"Joharapurkar","year":"2018","journal-title":"J. Med. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"CD011893","DOI":"10.1002\/14651858.CD011893.pub2","article-title":"Beta-blockers for Prevention and Treatment of Retinopathy of Prematurity in Preterm Infants","volume":"3","author":"Kaempfen","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s40272-021-00452-4","article-title":"Mirabegron: Pediatric First Approval","volume":"23","author":"Keam","year":"2021","journal-title":"Paediatr. Drugs"},{"key":"B65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1600-0420.2005.00548.x","article-title":"Laser Photocoagulation for Retinopathy of Prematurity: Structural and Functional Outcome","volume":"84","author":"Kieselbach","year":"2006","journal-title":"Acta Ophthalmol. Scand."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e500","DOI":"10.1542\/neo.20-9-e500","article-title":"Oxygen Therapy for Neonatal Resuscitation in the Delivery Room","volume":"20","author":"Kim","year":"2019","journal-title":"Neoreviews"},{"key":"B67","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","article-title":"Retinopathy of Prematurity: a Review of Risk Factors and Their Clinical Significance","volume":"63","author":"Kim","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"631673","DOI":"10.3389\/fped.2021.631673","article-title":"Clinical Efficacy and Safety of Propranolol in the Prevention and Treatment of Retinopathy of Prematurity: A Meta-Analysis of Randomized Controlled Trials","volume":"9","author":"Kong","year":"2021","journal-title":"Front. Pediatr."},{"key":"B69","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3109\/02713683.2016.1158272","article-title":"The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index","volume":"42","author":"Korkmaz","year":"2017","journal-title":"Curr. Eye Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.3390\/jcm10204631","article-title":"Infantile Hemangiomas: An Update on Pathogenesis and Treatment","volume":"10","author":"Kowalska","year":"2021","journal-title":"J. Clin. Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1177\/1947601911423654","article-title":"Hypoxia-induced Angiogenesis: Good and Evil","volume":"2","author":"Krock","year":"2011","journal-title":"Genes Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for Severe Hemangiomas of Infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A Randomized, Controlled Trial of Oral Propranolol in Infantile Hemangioma","volume":"372","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.siny.2011.08.007","article-title":"Perinatal Infection, Inflammation, and Retinopathy of Prematurity","volume":"17","author":"Lee","year":"2012","journal-title":"Semin. Fetal Neonatal. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12886-018-0685-6","article-title":"Comparison of Efficacy between Anti-vascular Endothelial Growth Factor (VEGF) and Laser Treatment in Type-1 and Threshold Retinopathy of Prematurity (ROP)","volume":"18","author":"Li","year":"2018","journal-title":"BMC Ophthalmol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nm1750","article-title":"A GRK5 Polymorphism that Inhibits Beta-Adrenergic Receptor Signaling Is Protective in Heart Failure","volume":"14","author":"Liggett","year":"2008","journal-title":"Nat. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/archdischild-2013-303951","article-title":"Oral Propranolol versus Placebo for Retinopathy of Prematurity: a Pilot, Randomised, Double-Blind Prospective Study","volume":"98","author":"Makhoul","year":"2013","journal-title":"Arch. Dis. Child."},{"key":"B78","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1476-5381.1996.tb15209.x","article-title":"Functional Identification of Rat Atypical Beta-Adrenoceptors by the First Beta 3-selective Antagonists, Aryloxypropanolaminotetralins","volume":"117","author":"Manara","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e20161609","DOI":"10.1542\/peds.2016-1609","article-title":"Oxygen Saturation Targets in Preterm Infants and Outcomes at 18-24 Months: A Systematic Review","volume":"139","author":"Manja","year":"2017","journal-title":"Pediatrics"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1471-4159.2011.07530.x","article-title":"Antiangiogenic Effects of \u03b22 -adrenergic Receptor Blockade in a Mouse Model of Oxygen-Induced Retinopathy","volume":"119","author":"Martini","year":"2011","journal-title":"J. Neurochem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.3390\/cells9122584","article-title":"The Beta3 Adrenergic Receptor in Healthy and Pathological Cardiovascular Tissues","volume":"9","author":"Michel","year":"2020","journal-title":"Cells"},{"key":"B82","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B83","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41372-017-0037-z","article-title":"Automated versus Manual Control of Inspired Oxygen to Target Oxygen Saturation in Preterm Infants: a Systematic Review and Meta-Analysis","volume":"38","author":"Mitra","year":"2018","journal-title":"J. Perinatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.neuint.2019.03.008","article-title":"Pharmacological HIF Inhibition Prevents Retinal Neovascularization with Improved Visual Function in a Murine Oxygen-Induced Retinopathy Model","volume":"128","author":"Miwa","year":"2019","journal-title":"Neurochem. Int."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1161\/01.cir.103.12.1649","article-title":"Upregulation of Beta(3)-Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium","volume":"103","author":"Moniotte","year":"2001","journal-title":"Circulation"},{"key":"B86","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/archopht.1988.01060130517027","article-title":"Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Preliminary Results. Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"106","author":"Multicenter trial","year":"1988","journal-title":"Arch. Ophthalmol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1016\/j.molcel.2021.06.024","article-title":"Cryo-EM Structure of the \u03b23-adrenergic Receptor Reveals the Molecular Basis of Subtype Selectivity","volume":"81","author":"Nagiri","year":"2021","journal-title":"Mol. Cel."},{"key":"B88","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/s0161-6420(01)01017-x","article-title":"A Comparison of Laser Photocoagulation with Cryotherapy for Threshold Retinopathy of Prematurity at 10 years: Part 1. Visual Function and Structural Outcome","volume":"109","author":"Ng","year":"2002","journal-title":"Ophthalmology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/s0161-6420(01)00841-7","article-title":"Association of Candidemia and Retinopathy of Prematurity in Very Low Birthweight Infants","volume":"109","author":"Noyola","year":"2002","journal-title":"Ophthalmology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s10792-018-1018-8","article-title":"The Efficacy of Propranolol in Very Preterm Infants at the Risk of Retinopathy of Prematurity: Which Newborn and when?","volume":"39","author":"Ozturk","year":"2019","journal-title":"Int. Ophthalmol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/pr.2014.108","article-title":"Pharmacokinetics and Local Safety Profile of Propranolol Eye Drops in Rabbits","volume":"76","author":"Padrini","year":"2014","journal-title":"Pediatr. Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.3390\/cells9122625","article-title":"Effect of Beta 3 Adrenoreceptor Modulation on Patency of the Ductus Arteriosus","volume":"9","author":"Pini","year":"2020","journal-title":"Cells"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s00417-014-2716-1","article-title":"Risk Factors for Retinopathy of Prematurity: Insights from Outlier Infants","volume":"252","author":"Port","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e2020039966","DOI":"10.1542\/peds.2020-039966","article-title":"Trends in Retinopathy of Prematurity Screening and Treatment: 2008-2018","volume":"147","author":"Prakalapakorn","year":"2021","journal-title":"Pediatrics"},{"key":"B95","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1089\/jop.2020.0092","article-title":"Ocular versus Oral Propranolol for Prevention And\/or Treatment of Oxygen-Induced Retinopathy in a Rat Model","volume":"37","author":"Qadri","year":"2021","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jamaophthalmol.2018.4290","article-title":"Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study","volume":"136","author":"Quinn","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000454917","article-title":"Hyperoxia and the Immature Brain","volume":"38","author":"Reich","year":"2016","journal-title":"Dev. Neurosci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1167\/iovs.10-5536","article-title":"Role of the Adrenergic System in a Mouse Model of Oxygen-Induced Retinopathy: Antiangiogenic Effects of Beta-Adrenoreceptor Blockade","volume":"52","author":"Ristori","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1152\/jappl.1983.55.3.750","article-title":"Effects of Hypoxia on Norepinephrine Release and Metabolism in Dog Pulmonary Artery","volume":"55","author":"Rorie","year":"1983","journal-title":"J. Appl. Physiol. Respir. Environ. Exerc. Physiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/s00431-021-03982-8","article-title":"The Effect of Automated Oxygen Control on Clinical Outcomes in Preterm Infants: a Pre- and post-implementation Cohort Study","volume":"180","author":"Salverda","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"B101","doi-asserted-by":"publisher","first-page":"F389","DOI":"10.1136\/archdischild-2016-311548","article-title":"Prophylactic Propranolol for Prevention of ROP and Visual Outcome at 1\u2005year (PreROP Trial)","volume":"102","author":"Sanghvi","year":"2017","journal-title":"Arch. Dis. Child. Fetal Neonatal. Ed."},{"key":"B102","doi-asserted-by":"publisher","first-page":"CD009734","DOI":"10.1002\/14651858.CD009734.pub3","article-title":"Anti-vascular Endothelial Growth Factor (VEGF) Drugs for Treatment of Retinopathy of Prematurity","volume":"1","author":"Sankar","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"B103","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1001\/archopht.1997.01100150606005","article-title":"Racial Variation in Retinopathy of Prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"115","author":"Saunders","year":"1997","journal-title":"Arch. Ophthalmol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1001\/jama.2013.5555","article-title":"Effects of Targeting Higher vs Lower Arterial Oxygen Saturations on Death or Disability in Extremely Preterm Infants: a Randomized Clinical Trial","volume":"309","author":"Schmidt","year":"2013","journal-title":"JAMA"},{"key":"B105","doi-asserted-by":"publisher","first-page":"19898","DOI":"10.1073\/pnas.0805817105","article-title":"Prolyl Hydroxylase Inhibition during Hyperoxia Prevents Oxygen-Induced Retinopathy","volume":"105","author":"Sears","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B106","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1152\/physiol.00001.2004","article-title":"Hydroxylation of HIF-1: Oxygen Sensing at the Molecular Level","volume":"19","author":"Semenza","year":"2004","journal-title":"Physiology (Bethesda)"},{"key":"B107","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41433-019-0643-4","article-title":"Retinopathy of Prematurity Treatment: Asian Perspectives","volume":"34","author":"Sen","year":"2020","journal-title":"Eye (Lond)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.3390\/cancers13112813","article-title":"An Overview of the Recent Development of Anticancer Agents Targeting the HIF-1 Transcription Factor","volume":"13","author":"Shirai","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B109","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/jamaophthalmol.2018.7021","article-title":"Comparison of Biphasic vs Static Oxygen Saturation Targets Among Infants with Retinopathy of Prematurity","volume":"137","author":"Shukla","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"B110","first-page":"101","article-title":"Oxygen-induced Retinopathy in the Mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41372-019-0503-x","article-title":"Oral Propranolol in Prevention of Severe Retinopathy of Prematurity: a Systematic Review and Meta-Analysis","volume":"39","author":"Stritzke","year":"2019","journal-title":"J. Perinatol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3760\/cma.j.issn.2096-2932.2018.04.007","article-title":"The Efficacy and Safety of Oral Propranolol in the Treatment of Retinopathy of Prematurity","volume":"33","author":"Sun","year":"2018","journal-title":"Chin. J. Neonatol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1542\/peds.105.2.295","article-title":"Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a Randomized, Controlled Trial. I: Primary Outcomes","volume":"105","author":"Supplemental","year":"2000","journal-title":"Pediatrics"},{"key":"B114","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.oret.2018.01.016","article-title":"The Genetics of Retinopathy of Prematurity: a Model for Neovascular Retinal Disease","volume":"2","author":"Swan","year":"2018","journal-title":"Ophthalmol. Retina."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/archophthalmol.2011.319","article-title":"Neonatal Bacteremia and Retinopathy of Prematurity: the ELGAN Study","volume":"129","author":"Tolsma","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/iovs.62.9.17","article-title":"Evaluation of the Effect of a Novel \u03b23-Adrenergic Agonist on Choroidal Vascularity","volume":"62","author":"Topcuoglu","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3389\/fphar.2020.00873","article-title":"Exploration of Oxygen-Induced Retinopathy Model to Discover New Therapeutic Drug Targets in Retinopathies","volume":"11","author":"V\u00e4h\u00e4tupa","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e0205838","DOI":"10.1371\/journal.pone.0205838","article-title":"Chorioamnionitis as a Risk Factor for Retinopathy of Prematurity: An Updated Systematic Review and Meta-Analysis","volume":"13","author":"Villamor-Martinez","year":"2018","journal-title":"PLoS One"},{"key":"B119","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00210-006-0127-5","article-title":"Tools to Study Beta3-Adrenoceptors","volume":"374","author":"Vrydag","year":"2007","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"21513","DOI":"10.1016\/s0021-9258(20)80571-7","article-title":"Characterization of Hypoxia-Inducible Factor 1 and Regulation of DNA Binding Activity by Hypoxia","volume":"268","author":"Wang","year":"1993","journal-title":"J. Biol. Chem."},{"key":"B121","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jaapos.2006.01.004","article-title":"Race, Gender, and Clinical Risk index for Babies (CRIB) Score as Predictors of Severe Retinopathy of Prematurity","volume":"10","author":"Yang","year":"2006","journal-title":"J. AAPOS."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1136\/bjophthalmol-2017-311576","article-title":"Association of Antenatal Steroid and Risk of Retinopathy of Prematurity: a Systematic Review and Meta-Analysis","volume":"102","author":"Yim","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e1576","DOI":"10.1542\/peds.2015-2372","article-title":"Human Milk Feeding as a Protective Factor for Retinopathy of Prematurity: A Meta-Analysis","volume":"136","author":"Zhou","year":"2015","journal-title":"Pediatrics"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.835771\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T07:23:01Z","timestamp":1642749781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.835771\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":123,"alternative-id":["10.3389\/fphar.2022.835771"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.835771","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"article-number":"835771"}}